Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 24

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 24
---
 Services Agreement with MicroSort International to use MicroSort equipment in Thailand and
in March 2019, Phnom Penh Center entered into a Lease and Services Agreement with MicroSort International to use MicroSort equipment
in Cambodia (together, the “Lease and Services Agreements”). Pursuant to the Lease and Services Agreements, First Fertility
PGS and Phnom Penh Center each had the exclusive right to utilize the MicroSort equipment and to market and sell MicroSort sperm sorting
services in Thailand and Cambodia, respectively. MicroSort International was responsible for the maintenance of MicroSort equipment and
technical and engineering support. The term of each Lease and Service Agreements was initially from 2019 to 2024, which shall be automatically
renewed for one year unless a written notice of at least 180 days prior to the intended termination date is provided. The consideration
under each of the Lease and Services Agreements was US$9,000 per month after six months.

<div align='center'>9</div>

On January 21, 2025, the Company entered into a Purchase Agreement
with Genetics & IVF Institute, Inc. (“Purchase Agreement”), pursuant to which the Company purchased all of the Assets
(as defined in the Purchase Agreement) and IP Licenses (as defined in the Purchase Agreement) relating to the MicroSort Business (as defined
in the Purchase Agreement) from Genetics & IVF Institute, Inc. for a cash consideration of $750,000 and a share consideration of 125,000
Class A Ordinary Shares (“Share Consideration”). The Purchase Agreement is filed as Exhibit 10.30 of the Form F-1 registration
statement filed on May 29, 2025. MicroSort Lab Services, LLC (“MicroSort”) was incorporated by Genetics & IVF Institute,
Inc. in January 2025 to hold all of the Assets (as defined in the Purchase Agreement) to be transferred to the Company at closing. The
Company’s acquisition of MicroSort was completed on February 28, 2025, and the Share Consideration was issued to GIVF on the same
day.

The flow chart below shows
the process involved in MicroSort:

Preimplantation Genetic Screening

PGS is used in parallel with an IVF treatment cycle. PGS is the practice of determining the presence of aneuploidy (either too many or too few chromosomes) in a developing embryo. PGS improves success rates of in vitro fertilization by ensuring